Drug recall · January 22, 2014
DOXEPIN HCL Capsule recall
Why: Labeling: Label Mixup; DOXEPIN HCL Capsule, 150 mg may be potentially mislabeled as VALSARTAN, Tablet, 160 mg, NDC 00078035934, Pedigree: AD46312_7, EXP: 5/16/2014.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
DOXEPIN HCL Capsule, 150 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 49884022201
- Lots / codes
DOXEPIN HCL, Capsule, 150 mg has the following code Pedigree: AD46312_10, EXP: 5/16/2014.
- Quantity
- 100 Capsules
- Company
- Aidapak Services, LLC, Vancouver, WA
- Distribution
- Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
- Initiated
- July 2, 2013 · Voluntary: Firm initiated
- Classified
- January 16, 2014
- Reported
- January 22, 2014
- Ended
- February 7, 2014
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Doxepin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.